Basque enterprise blog Receive daily information of interest to your company

18 July, 2016
IK4-CIDETEC coordinates the EU PneumoNP project in the context of the “Nanotherapeutics to treat bacterial infectious diseases” call

The PneumoNP project is expecting to assist the fight against the phenomenon of bacterial resistance to antibiotics

The project has a multidisciplinary character and faces the challenge to develop a new inhalation system specifically designed by the partner INGENIATRICS (Spain) to achieve efficient delivery of novel nanopharmaceuticals into the lungs. The nanopharmaceuticals will consist of a nanocarrier (NC) functionalized with an antimicrobial peptide (AMP). IK4-CIDETEC contributes to the NC with single-chain polymer nanoparticles and Utrecht University with liposomes. Two SMEs (SETLANCE – Italy and ADENIUM BIOTECH – Denmark) are producing AMPs which are being loaded to the nanocarriers and tested in vitro (ITEM Fraunhofer – Germany) and in vivo (clinicians at Erasmus Medical Centre Rotterdam – The Netherlands) against different strains of bacteria in order to select the most efficient and promising nanopharmaceuticals. Furthermore, the research centre CIC biomaGUNE (Spain) is studying the in vivo biodistribution of selected AMP-NC systems in order to select the ones which are better retained in lungs. In parallel, a detection kit is being developed by SME PATHOFINDER (The Netherlands) through the development of Multiplex PCR Diagnostics for Infectious Diseases. The consortium comprises two more organizations: the project manager EURICE (Germany) and partner UMAPS (France) devoted to dissemination and exploitation.


The project has been planned to reach a pre-clinical phase and to set the basis to further developing the best performance NC-AMPs in GMP conditions to facilitate translation to the clinic in the future.


The PneumoNP project is expecting to generate new knowledge in the field of nanotechnology-based therapeutics and to assist the fight against the phenomenon of bacterial resistance to antibiotics, a major health issue alarm which is considered urgent not only in Europe. In this sense, PneumoNP has also participated in the European Antibiotics Awareness Day (EAAD) organizing an open door talk for citizens on the 18th November 2015 “Let’s talk about the proper use of antibiotics!” with the aim of sensitize the society to this hurdle and make it aware of the efforts that scientists are carrying out.

Basque Industry 29 April, 2020
Materials 4.0: Three state-of-the-art surface modification techniques for your industrial components

At the moment, Basque business is living through times of change and experiencing an unusual and...Leer más

Basque Industry 15 April, 2020
Materials 4.0: producing better performing, more durable and more sustainable products in the Basque Country!

The SPRI Group, together with the BDIH, makes the Advanced Materials Node available to Basque SMEs....Leer más

Basque Industry 7 April, 2020
The Closing Word on… Robotics

Damien Sallé, Cross-departmental Coordinator of Robotic Technology at Tecnalia and Head of Market...Leer más

Basque Industry 2 April, 2020
384,000 industrial robots and co-bots in the Basque Country

Robotic 4.0 solutions to support collaborative and flexible manufacturing. In the context of our...Leer más

Basque Industry 27 March, 2020
4.0 solutions: robotics for quality control

In this article from our "solutions 4.0" series we present the robots that provide the solution to...Leer más


Daily information segmented according to business
sectors and countries of interest to make the most competitive

Latest news about New Subsidies

For SMEs, for diversifying markets, internships abroad, international tenders, non-reimbursable subsidies to consolidate exports, subsidies for deployments or specific training in internationalisation.

You’re interested, right?